FIGURE 3.
Intravenously administered JS-K signifi cantly improved survival of mice bearing xenografts of OPM-1 multiple myeloma cells. (Adapted from Kiziltepe et al., 2007.7 Copyright American Society of Hematology.)
Intravenously administered JS-K signifi cantly improved survival of mice bearing xenografts of OPM-1 multiple myeloma cells. (Adapted from Kiziltepe et al., 2007.7 Copyright American Society of Hematology.)